Axogen, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Axogen, Inc. (AXGN) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $8.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-29
- Axogen, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $8.77M, a 69.62% increase year-over-year.
- Axogen, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $6.84M, a 135.24% increase year-over-year.
- Axogen, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $16.61M, a 440.02% increase year-over-year.
- Axogen, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.42M, a 8.39% increase year-over-year.
- Axogen, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $30.11M, a 89.31% increase from fiscal 2024.
- Axogen, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $15.91M, a 10.32% increase from fiscal 2023.
- Axogen, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $14.42M, a 7.52% decline from fiscal 2022.
- Axogen, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $15.59M, a 42.79% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $8.77M 10-Q · filed 2026-07-29 | $15.61M 10-Q · filed 2026-07-29 | $32.22M derived: sum of 3 quarters · filed 2026-07-29 | $37.64M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | $6.84M 10-Q · filed 2026-04-28 | $23.45M derived: sum of 2 quarters · filed 2026-04-28 | $28.88M derived: sum of 3 quarters · filed 2026-04-28 | $34.05M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | $16.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $22.04M derived: sum of 2 quarters · filed 2026-02-24 | $27.20M derived: sum of 3 quarters · filed 2026-07-29 | $30.11M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $5.42M 10-Q · filed 2025-10-29 | $10.59M derived: sum of 2 quarters · filed 2026-07-29 | $13.50M 10-Q · filed 2025-10-29 | $16.58M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $5.17M 10-Q · filed 2026-07-29 | $8.08M 10-Q · filed 2026-07-29 | $11.15M derived: sum of 3 quarters · filed 2026-07-29 | $16.16M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $2.91M 10-Q · filed 2026-04-28 | $5.99M derived: sum of 2 quarters · filed 2026-04-28 | $10.99M derived: sum of 3 quarters · filed 2026-04-28 | $14.90M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.08M derived: sum of 2 quarters · filed 2026-02-24 | $11.99M derived: sum of 3 quarters · filed 2026-02-24 | $15.91M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $5.00M 10-Q · filed 2025-10-29 | $8.91M derived: sum of 2 quarters · filed 2025-10-29 | $12.83M 10-Q · filed 2025-10-29 | $14.16M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $3.91M 10-Q · filed 2025-08-05 | $7.83M 10-Q · filed 2025-08-05 | $9.15M derived: sum of 3 quarters · filed 2026-02-24 | $13.90M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $3.92M 10-Q · filed 2025-05-08 | $5.25M derived: sum of 2 quarters · filed 2026-02-24 | $9.99M derived: sum of 3 quarters · filed 2026-02-24 | $15.38M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.07M derived: sum of 2 quarters · filed 2026-02-24 | $11.46M derived: sum of 3 quarters · filed 2026-02-24 | $14.42M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $4.75M 10-Q · filed 2024-11-07 | $10.14M derived: sum of 2 quarters · filed 2024-11-07 | $13.09M 10-Q · filed 2024-11-07 | $17.25M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $5.39M 10-Q · filed 2024-08-08 | $8.34M 10-Q · filed 2024-08-08 | $12.50M derived: sum of 3 quarters · filed 2025-02-26 | $16.35M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $2.95M 10-Q · filed 2024-05-02 | $7.11M derived: sum of 2 quarters · filed 2025-02-26 | $10.96M derived: sum of 3 quarters · filed 2025-02-26 | $15.87M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $8.00M derived: sum of 2 quarters · filed 2025-02-26 | $12.91M derived: sum of 3 quarters · filed 2025-02-26 | $15.59M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $3.85M 10-Q · filed 2023-11-07 | $8.76M derived: sum of 2 quarters · filed 2023-11-07 | $11.44M 10-Q · filed 2023-11-07 | $12.95M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | $4.91M 10-Q · filed 2023-08-08 | $7.59M 10-Q · filed 2023-08-08 | $9.10M derived: sum of 3 quarters · filed 2024-03-05 | $12.01M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | $2.68M 10-Q · filed 2023-05-09 | $4.19M derived: sum of 2 quarters · filed 2024-03-05 | $7.10M derived: sum of 3 quarters · filed 2024-03-05 | $10.90M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $4.42M derived: sum of 2 quarters · filed 2024-03-05 | $8.22M derived: sum of 3 quarters · filed 2024-03-05 | $10.92M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $2.91M 10-Q · filed 2022-11-08 | $6.71M derived: sum of 2 quarters · filed 2022-11-08 | $9.41M 10-Q · filed 2022-11-08 | $12.15M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-06-30 | $3.80M 10-Q · filed 2022-08-05 | $6.50M 10-Q · filed 2022-08-05 | $9.24M derived: sum of 3 quarters · filed 2023-03-14 | $12.19M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-03-31 | $2.69M 10-Q · filed 2022-05-05 | $5.44M derived: sum of 2 quarters · filed 2023-03-14 | $8.39M derived: sum of 3 quarters · filed 2023-03-14 | $10.61M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2020-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $5.69M derived: sum of 2 quarters · filed 2023-03-14 | $7.91M derived: sum of 3 quarters · filed 2023-03-14 | $8.47M 10-K · filed 2023-03-14 | |
| 2020-09-30 | $2.95M 10-Q · filed 2021-11-04 | $5.17M derived: sum of 2 quarters · filed 2021-11-04 | $5.72M 10-Q · filed 2021-11-04 | $8.64M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $2.22M 10-Q · filed 2021-08-05 | $2.78M 10-Q · filed 2021-08-05 | $5.70M derived: sum of 3 quarters · filed 2022-02-25 | $8.10M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $556.00K 10-Q · filed 2021-05-06 | $3.48M derived: sum of 2 quarters · filed 2022-02-25 | $5.87M derived: sum of 3 quarters · filed 2022-02-25 | $8.55M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $5.32M derived: sum of 2 quarters · filed 2022-02-25 | $7.99M derived: sum of 3 quarters · filed 2022-02-25 | $10.30M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $2.40M 10-Q · filed 2020-10-30 | $5.07M derived: sum of 2 quarters · filed 2020-10-30 | $7.38M 10-Q · filed 2020-10-30 | $9.01M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $2.67M 10-Q · filed 2020-08-07 | $4.99M 10-Q · filed 2020-08-07 | $6.61M derived: sum of 3 quarters · filed 2021-03-01 | $8.82M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $2.31M 10-Q · filed 2020-05-06 | $3.94M derived: sum of 2 quarters · filed 2021-03-01 | $6.15M derived: sum of 3 quarters · filed 2021-03-01 | $8.19M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.84M derived: sum of 2 quarters · filed 2021-03-01 | $5.88M derived: sum of 3 quarters · filed 2021-03-01 | $7.61M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $2.21M 10-Q · filed 2019-11-06 | $4.25M derived: sum of 2 quarters · filed 2019-11-06 | $5.98M 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $2.04M 10-Q · filed 2019-08-06 | $3.77M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $1.73M 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | $3.61M 10-K · filed 2020-02-24 | $3.61M 10-K · filed 2018-02-28 | |||
| 2016-12-31 | $1.39M 10-K · filed 2019-02-26 | $1.39M 10-K · filed 2017-03-01 | |||
| 2015-12-31 | $1.32M 10-K · filed 2018-02-28 | ||||
| 2014-12-31 | $956.45K 10-K · filed 2016-02-29 | ||||
| 2013-12-31 | $671.89K 10-K · filed 2015-03-05 | ||||
| 2012-12-31 | $495.08K 10-K · filed 2014-03-06 | ||||
| 2011-12-31 | $250.04K 10-K/A · filed 2013-08-07 | ||||
| 2010-12-31 | $187.46K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |